Serine protease inhibitors (serpins)
- 1 May 1991
- journal article
- review article
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 1 (4) , 146-151
- https://doi.org/10.1016/1050-1738(91)90019-b
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy.Journal of Clinical Investigation, 1990
- Evaluation of the safety, recovery, half-life, and clinical efficacy of antithrombin III (human) in patients with hereditary antithrombin III deficiency. Cooperative Study Group [see comments]Blood, 1990
- Implications of the three-dimensional structure of .alpha.1-antitrypsin for structure and function of serpinsBiochemistry, 1989
- Serpin-resistant mutants of human tissue-type plasminogen activatorNature, 1989
- A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.Journal of Clinical Investigation, 1988
- Multiple tissues express alpha 1-antitrypsin in transgenic mice and man.Journal of Clinical Investigation, 1988
- Cell-specific expression of a transfected human α1-antitrypsin geneCell, 1985
- Synthesis in E. coli of α1-antitrypsin variants of therapeutic potential for emphysema and thrombosisNature, 1985
- Mutation of Antitrypsin to AntithrombinNew England Journal of Medicine, 1983
- Treatment of Hereditary Angioedema with DanazolNew England Journal of Medicine, 1976